These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2080855)

  • 21. Diagnosis and management of defects of mitochondrial beta-oxidation.
    Vockley J; Singh RH; Whiteman DA
    Curr Opin Clin Nutr Metab Care; 2002 Nov; 5(6):601-9. PubMed ID: 12394635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosing disorders of fatty acid oxidation.
    Nyhan WL
    Clin Chem; 1995 Jan; 41(1):10-1. PubMed ID: 7813054
    [No Abstract]   [Full Text] [Related]  

  • 23. [Mitochondrial trifunctional protein].
    Uchiyama A; Yamaguchi S
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():109-12. PubMed ID: 12013829
    [No Abstract]   [Full Text] [Related]  

  • 24. Fifty years of research on mitochondrial fatty acid oxidation disorders: The remaining challenges.
    Vianey-Saban C; Guffon N; Fouilhoux A; Acquaviva C
    J Inherit Metab Dis; 2023 Sep; 46(5):848-873. PubMed ID: 37530674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hepatic mitochondrial fatty acid oxidation disorders].
    Matsubara Y
    Ryoikibetsu Shokogun Shirizu; 1995; (8):312-6. PubMed ID: 8581639
    [No Abstract]   [Full Text] [Related]  

  • 26. Do criteria exist from urinary organic acids to distinguish beta-oxidation defects?
    Rabier D; Bardet J; Parvy P; Poggi F; Brivet M; Saudubray JM; Kamoun P
    J Inherit Metab Dis; 1995; 18(2):257-60. PubMed ID: 7564262
    [No Abstract]   [Full Text] [Related]  

  • 27. [Mitochondrial 3-ketoacyl-CoA thiolase].
    Yamaguchi S; Kanai R
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():105-8. PubMed ID: 12013828
    [No Abstract]   [Full Text] [Related]  

  • 28. Inborn errors of metabolism associated with unusual odors.
    Carpenter DG; Carter CH
    J Fla Med Assoc; 1970 May; 57(5):31-3. PubMed ID: 5449191
    [No Abstract]   [Full Text] [Related]  

  • 29. Analysis of carnitine esters by radio-high performance liquid chromatography in cultured skin fibroblasts from patients with mitochondrial fatty acid oxidation disorders.
    Schmidt-Sommerfeld E; Bobrowski PJ; Penn D; Rhead WJ; Wanders RJ; Bennett MJ
    Pediatr Res; 1998 Aug; 44(2):210-4. PubMed ID: 9702916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel functional assay for simultaneous determination of total fatty acid beta-oxidation flux and acylcarnitine profiling in human skin fibroblasts using (2)H(31)-palmitate by isotope ratio mass spectrometry and electrospray tandem mass spectrometry.
    Law LK; Tang NL; Hui J; Ho CS; Ruiter J; Fok TF; Wanders RJ; Lam CW
    Clin Chim Acta; 2007 Jul; 382(1-2):25-30. PubMed ID: 17442290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mitochondrial 3-hydroxyacyl-CoA dehydrogenase (SCHAD, LCHAD)].
    Yamaguchi S
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():101-4. PubMed ID: 12013827
    [No Abstract]   [Full Text] [Related]  

  • 32. Fatty acid metabolism in mitochondria: defects and genetics.
    Coates PM
    Biofactors; 1998; 7(3):201-2. PubMed ID: 9568246
    [No Abstract]   [Full Text] [Related]  

  • 33. ESI-MS/MS study of acylcarnitine profiles in urine from patients with organic acidemias and fatty acid oxidation disorders.
    Kobayashi H; Hasegawa Y; Endo M; Purevsuren J; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):80-7. PubMed ID: 17301002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling disorders of fatty acid metabolism in the mouse.
    Goetzman ES
    Prog Mol Biol Transl Sci; 2011; 100():389-417. PubMed ID: 21377632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The contribution of the laboratory in the diagnosis of hereditary intermediate metabolism disorders].
    Khiari D; Tebib N; Kaabachi N; Ben Dridi MF; Mebazaa A
    Tunis Med; 1995 May; 73(5):159-67. PubMed ID: 9507277
    [No Abstract]   [Full Text] [Related]  

  • 36. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
    Stanley CA
    Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid diagnosis of long chain and medium chain fatty acid oxidation disorders using lymphocytes.
    Brivet M; Slama A; Saudubray JM; Legrand A; Lemonnier A
    Ann Clin Biochem; 1995 Mar; 32 ( Pt 2)():154-9. PubMed ID: 7785942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heat stress deteriorates mitochondrial beta-oxidation of long-chain fatty acids in cultured fibroblasts with fatty acid beta-oxidation disorders.
    Li H; Fukuda S; Hasegawa Y; Purevsuren J; Kobayashi H; Mushimoto Y; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1669-72. PubMed ID: 20207594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.
    Jakobs C; Kneer J; Martin D; Boulloche J; Brivet M; Poll-The BT; Saudubray JM
    Eur J Pediatr; 1997 Aug; 156 Suppl 1():S78-82. PubMed ID: 9266222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Child neurology: Recurrent rhabdomyolysis due to a fatty acid oxidation disorder.
    Terrone G; Ruoppolo M; Brunetti-Pierri N; Cozzolino C; Scolamiero E; Parenti G; Romano A; Andria G; Salvatore F; Frisso G
    Neurology; 2014 Jan; 82(1):e1-4. PubMed ID: 24379101
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.